Sponsor or institution
Clinical trials and research at Guangzhou University of Traditional Chinese Medicine
As of November 12, 2026, Find a Trial lists 7 clinical trials run by Guangzhou University of Traditional Chinese Medicine that are recruiting, in China. By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 7Clinical trials
- 1Country
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Befotertinib plus chemo with MRD-guided escalation for EGFR-mutant NSCLC | Phase 2 | Guangzhou, Guangdong and 1 other locations | Recruiting | Jul 16, 2026 |
| Pulsatile high-dose furmonertinib for EGFR-mutant NSCLC with leptomeningeal metastasis | — | Guangzhou, Guangdong | Recruiting | Jan 16, 2026 |
| Electro-Acupuncture plus PD-1 inhibitors and chemotherapy in advanced NSCLC | — | Guangzhou, Guangdong and 2 other locations | Recruiting | Jan 13, 2026 |
| Real-world Chinese medicine treatment for chikungunya fever | — | Guangzhou, Guangdong | Recruiting | Aug 13, 2025 |
| Using Xiao Chai Hu Tang to prevent diarrhea from irinotecan chemotherapy | — | Guangzhou, Guangdong | Recruiting | Sep 26, 2023 |
| HGXJT plus immune therapy for non-small cell lung cancer that has spread to the bones | — | Guangzhou, Guangdong | Recruiting | May 18, 2022 |
| Cohort study on Dampness Syndrome in Traditional Chinese Medicine | — | Guangzhou, Guangdong | Recruiting | Apr 7, 2022 |
All recruiting trials (7)
-
Befotertinib plus chemo with MRD-guided escalation for EGFR-mutant NSCLC
This phase 2 trial tests whether starting befotertinib and then using MRD results to guide adding chemotherapy improves outcomes for adults with EGFR-mutant advanced NSCLC.
-
Pulsatile high-dose furmonertinib for EGFR-mutant NSCLC with leptomeningeal metastasis
This tests whether taking high-dose furmonertinib every other day helps people with EGFR-mutant non-small cell lung cancer that has spread to the leptomeninges.
-
Electro-Acupuncture plus PD-1 inhibitors and chemotherapy in advanced NSCLC
This trial tests whether adding electro-acupuncture to first-line PD-1 inhibitors plus chemotherapy helps people with advanced NSCLC who have no targetable mutations.
-
Real-world Chinese medicine treatment for chikungunya fever
This project will try Chinese medicine alone or together with Western medicines to relieve symptoms in people with early chikungunya fever.
-
Using Xiao Chai Hu Tang to prevent diarrhea from irinotecan chemotherapy
This study is testing whether a traditional herbal remedy called Xiao Chai Hu Tang can help prevent severe diarrhea in cancer patients receiving irinotecan chemotherapy.
-
HGXJT plus immune therapy for non-small cell lung cancer that has spread to the bones
This trial tests whether adding HGXJT, a traditional Chinese herbal formula, to standard immune checkpoint inhibitor treatment helps people with non-small cell lung cancer that has bone metastases.
-
Cohort study on Dampness Syndrome in Traditional Chinese Medicine
This study is looking at how Dampness Syndrome in Traditional Chinese Medicine might be linked to chronic diseases like diabetes, cancer, and dementia in people aged 35 to 75 over five years.
Quick answers
How many clinical trials run by Guangzhou University of Traditional Chinese Medicine are recruiting right now?
7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.